CI Private Wealth »

Monte Rosa Therapeutics shares owned by CI Private Wealth

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by CI Private Wealth from 13F filings

Historical chart of CI Private Wealth investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by CI Private Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by CI Private Wealth

Quarter filed Position value Share count Share price at filing
2026-03-31 $311k 19k 16.45

More positions owned by CI Private Wealth

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Costco Wholesale Corporation (COST)
Johnson & Johnson (JNJ)

View all positions for CI Private Wealth

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BlackRock
TCG Crossover Management
BVF
Baker Bros. Advisors
Suvretta Capital Management
Vestal Point Capital
Vanguard Group
Braidwell
Versant Venture Management
Vanguard Capital Management
State Street Corporation
Aisling Capital Management
Geode Capital Management
American Century Companies

View all funds holding Monte Rosa Therapeutics